Tarlatamab: a potential new option for recurrent small cell lung cancer.

ABSTRACT:

SUBMITTER: Addeo A 

PROVIDER: S-EPMC10413042 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature